Additionally, genetic deletion of the Ccr5 gene or in vivo overexpression of a dominant negative form of the CCR5 ligand, CCL5, attenuated tumor formation in this model together with reduced fibroblast accumulation. This evidence concerns the gene CCL5 and neoplasm.